Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase InhibitorsAntonia F. Stepan, R. Scott Obach, W. Scott McDonald et al.|Journal of Medicinal Chemistry|2011Cited by 106